- Bed Bath & Beyond Inc BBBY reported a third-quarter FY22 sales decline of 33% year-on-year to $1.26 billion, missing the consensus of $1.34 billion. Comparable sales decreased 32%.
- Adjusted gross margin contracted 1,310 basis points to 22.8%. Adjusted EBITDA loss was $(224.9) million, with an adjusted EBITDA margin of (17.9)%.
- Selling, general and administrative expenses fell 16.4% to $583.5 million.
- Operating loss for the quarter expanded to $(450.9) million versus a loss of $(86.1) million last year.
- Related: Bed Bath & Beyond Seeks Strategic Options, Including Bankruptcy
- Adjusted EPS loss was $(3.65), missing the consensus of $(2.11).
- Net cash used in operating activities during the quarter was $(307.6) million. It ended the quarter with cash and equivalents of $225.66 million.
- "As we shared last week, we continue to work with advisors as we consider all strategic alternatives to accomplish our near- and long-term goals. We have a team, internally and externally, with proven experience helping companies successfully navigate complex situations and become stronger. Multiple paths are being explored and we are determining our next steps thoroughly, and in a timely manner," said CEO Sue Gove.
- Also Read: Bed Bath & Beyond Stock Gained On M&A Speculation And Meme Stock Frenzy
- Price Action: BBBY shares are trading higher by 4.01% at $1.6850 in premarket on the last check Tuesday.
- Photo Via Wikimedia Commons
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in